Hydrazinecarbothioamide, 2-[1-(2-thienyl)ethylidene]-, (2Z)- manufacturers
- SSAA09E1
-
- $137.00
-
2026-07-27
- CAS:433212-75-0
- Purity:
- Supply Ability: 10g
|
| | Hydrazinecarbothioamide, 2-[1-(2-thienyl)ethylidene]-, (2Z)- Basic information |
| | Hydrazinecarbothioamide, 2-[1-(2-thienyl)ethylidene]-, (2Z)- Chemical Properties |
| Boiling point | 333.0±34.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Ethanol: soluble | | form | A crystalline solid | | pka | 11.50±0.70(Predicted) | | color | White to off-white |
| | Hydrazinecarbothioamide, 2-[1-(2-thienyl)ethylidene]-, (2Z)- Usage And Synthesis |
| Uses | SSAA09E1 is a cathepsin L blocker (IC50: 5.33 μM).SSAA09E1 inhibits stages of viral entry. SSAA09E1 can be used for SARS-CoV infection research[1] | | Biological Activity | SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.1 It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50 = 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50 = 5.33 μM) but not cathepsin B when used at a concentration of 20 μM. | | References | 1.() |
| | Hydrazinecarbothioamide, 2-[1-(2-thienyl)ethylidene]-, (2Z)- Preparation Products And Raw materials |
|